Approach to Neuropathic Pain

Abstract

Neuropathic pain is a common chief complaint encountered by neurologists and primary care providers. It is caused by disorders involving the somatosensory nervous system. The clinical evaluation of neuropathic pain is challenging and requires a multifaceted systematic approach with an emphasis on a thorough history and physical examination to identify characteristic signs and symptoms. Ancillary laboratory investigations, targeted imaging, and electrodiagnostic studies further help identify underlying etiologies to guide specific treatments. Management of neuropathic pain encompasses treating the underlying pathology as well as symptomatic control with nonpharmacological, pharmacological, and interventional therapies. Here, we present an approach to help evaluate patients with neuropathic pain.

Keywords

large fiber neuropathy - small fiber neuropathy - neuropathic pain - fibromyalgia - electromyography - nerve conduction studies - neuropathy screening

Publikationsverlauf

Artikel online veröffentlicht:
26. November 2021

• References

• 1 Treede R-D, Jensen TS, Campbell JN. et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70 (18) 1630-1635
• 2 Jensen TS, Baron R, Haanpää M. et al. A new definition of neuropathic pain. Pain 2011; 152 (10) 2204-2205
• 3 Scholz J, Finnerup NB, Attal N. et al; Classification Committee of the Neuropathic Pain Special Interest Group (NeuPSIG). The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain 2019; 160 (01) 53-59
• 4 Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010; 9 (08) 807-819
• 5 Attal N, Bouhassira D, Baron R. Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol 2018; 17 (05) 456-466
• 6 Bouhassira D, Attal N. Diagnosis and assessment of neuropathic pain: the saga of clinical tools. Pain 2011; 152 (3, Suppl): S74-S83
• 7 Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001; 92 (1-2): 147-157
• 8 Bennett MI, Attal N, Backonja MM. et al. Using screening tools to identify neuropathic pain. Pain 2007; 127 (03) 199-203
• 9 Bouhassira D, Attal N, Alchaar H. et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114 (1-2): 29-36
• 10 Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008; 136 (03) 380-387
• 11 Klingner CM, Witte OW. Somatosensory deficits. Handb Clin Neurol 2018; 151: 185-206
• 12 Zilliox LA. Neuropathic pain. Continuum (Minneap Minn) 2017; 23 (2, Selected Topics in Outpatient Neurology): 512-532
• 13 Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician. CMAJ 2006; 175 (03) 265-275
• 14 Kumar G, Soni CR. Central post-stroke pain: current evidence. J Neurol Sci 2009; 284 (1-2): 10-17
• 15 Siddall PJ, McClelland JM, Rutkowski SB, Cousins MJ. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 2003; 103 (03) 249-257
• 16 Svendsen KB, Jensen TS, Overvad K, Hansen HJ, Koch-Henriksen N, Bach FW. Pain in patients with multiple sclerosis: a population-based study. Arch Neurol 2003; 60 (08) 1089-1094
• 17 Watson JC, Sandroni P. Central neuropathic pain syndromes. Mayo Clin Proc 2016; 91 (03) 372-385
• 18 Wasner G. Central pain syndromes. Curr Pain Headache Rep 2010; 14 (06) 489-496
• 19 Alport AR, Sander HW. Clinical approach to peripheral neuropathy: anatomic localization and diagnostic testing. Continuum (Minneap Minn) 2012; 18 (01) 13-38
• 20 Bromberg MB. An approach to the evaluation of peripheral neuropathies. Semin Neurol 2005; 25 (02) 153-159
• 21 Vavra MW, Rubin DI. The peripheral neuropathy evaluation in an office-based neurology setting. Semin Neurol 2011; 31 (01) 102-114
• 22 Herskovitz S, Scelsa S, Schaumburg H. Peripheral Neuropathies in Clinical Practice. Vol. 76. Oxford University Press; 2010
• 23 Singer MA, Vernino SA, Wolfe GI. Idiopathic neuropathy: new paradigms, new promise. J Peripher Nerv Syst 2012; 17 (Suppl. 02) 43-49
• 24 Gordon Smith A, Robinson Singleton J. Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci 2006; 242 (1-2): 9-14
• 25 Macone A, Otis JA. Neuropathic pain. Semin Neurol 2018; 38 (06) 644-653
• 26 Oaklander AL, Lunn MP, Hughes RA, van Schaik IN, Frost C, Chalk CH. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev 2017; 1 (01) CD010369
• 27 Gierthmühlen J, Baron R. Neuropathic pain. Semin Neurol 2016; 36 (05) 462-468
• 28 Tesfaye S, Boulton AJ, Dyck PJ. et al; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33 (10) 2285-2293
• 29 Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain 1995; 61 (02) 187-193
• 30 Brouwer BA, Merkies IS, Gerrits MM, Waxman SG, Hoeijmakers JG, Faber CG. Painful neuropathies: the emerging role of sodium channelopathies. J Peripher Nerv Syst 2014; 19 (02) 53-65
• 31 Baron R, Hans G, Dickenson AH. Peripheral input and its importance for central sensitization. Ann Neurol 2013; 74 (05) 630-636
• 32 Meacham K, Shepherd A, Mohapatra DP, Haroutounian S. Neuropathic pain: central vs. peripheral mechanisms. Curr Pain Headache Rep 2017; 21 (06) 28
• 33 Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc 2015; 90 (04) 532-545
• 34 Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol 2014; 13 (09) 924-935
• 35 Jensen TS, Gottrup H, Sindrup SH, Bach FW. The clinical picture of neuropathic pain. Eur J Pharmacol 2001; 429 (1-3): 1-11
• 36 Yosipovitch G, Samuel LS. Neuropathic and psychogenic itch. Dermatol Ther 2008; 21 (01) 32-41
• 37 Putzke JD, Richards JS, Hicken BL, Ness TJ, Kezar L, DeVivo M. Pain classification following spinal cord injury: the utility of verbal descriptors. Spinal Cord 2002; 40 (03) 118-127
• 38 Smart KM, Blake C, Staines A, Doody C. The Discriminative validity of “nociceptive,” “peripheral neuropathic,” and “central sensitization” as mechanisms-based classifications of musculoskeletal pain. Clin J Pain 2011; 27 (08) 655-663
• 39 Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manage 2001; 21 (04) 338-354
• 40 Kanner RM. Pharmacological approaches to pain management. CONTINUUM: Lifelong Learning Neurol 2005; 11 (06) 137-154
• 41 Backonja M. The role of opioid therapy in the treatment of neuropathic pain. CONTINUUM: Lifelong Learning Neurol 2009; 15 (05) 84-100
• 42 Haanpää M, Attal N, Backonja M. et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011; 152 (01) 14-27
• 43 Beith ID, Kemp A, Kenyon J, Prout M, Chestnut TJ. Identifying neuropathic back and leg pain: a cross-sectional study. Pain 2011; 152 (07) 1511-1516
• 44 Backonja M-M, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neurol Clin 1998; 16 (04) 775-790
• 45 Bouhassira D, Attal N, Fermanian J. et al. Development and validation of the neuropathic pain symptom inventory. Pain 2004; 108 (03) 248-257
• 46 Lodahl M, Treister R, Oaklander AL. Specific symptoms may discriminate between fibromyalgia patients with vs without objective test evidence of small-fiber polyneuropathy. Pain Rep 2017; 3 (01) e633
• 47 Voortman M, Fritz D, Vogels OJM. et al. Small fiber neuropathy: a disabling and underrecognized syndrome. Curr Opin Pulm Med 2017; 23 (05) 447-457
• 48 Castelnuovo G, Giusti EM, Manzoni GM. et al. Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation. Front Psychol 2016; 7: 468
• 49 Torta R, Ieraci V, Zizzi F. A review of the emotional aspects of neuropathic pain: from comorbidity to co-pathogenesis. Pain Ther 2017; 6 (01, Suppl 1): 11-17
• 50 Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain 2007; 23 (02) 143-149
• 51 Ziadni MS, Sturgeon JA, Darnall BD. The relationship between negative metacognitive thoughts, pain catastrophizing and adjustment to chronic pain. Eur J Pain 2018; 22 (04) 756-762
• 52 Sheng J, Liu S, Wang Y, Cui R, Zhang X. The link between depression and chronic pain: neural mechanisms in the brain. Neural Plast 2017; 2017: 9724371
• 53 Patel R, Brice NL, Lewis RJ, Dickenson AH. Ionic mechanisms of spinal neuronal cold hypersensitivity in ciguatera. Eur J Neurosci 2015; 42 (11) 3004-3011
• 54 Zimmermann K, Deuis JR, Inserra MC. et al. Analgesic treatment of ciguatoxin-induced cold allodynia. Pain 2013; 154 (10) 1999-2006
• 55 Kumar B. Pure or primary neuritic leprosy (PNL). Lepr Rev 2016; 87 (04) 450-455
• 56 Sindic CJ. Infectious neuropathies. Curr Opin Neurol 2013; 26 (05) 510-515
• 57 Chen X, Haggiagi A, Tzatha E, DeAngelis LM, Santomasso B. Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy. Clin Neurophysiol 2019; 130 (08) 1440-1445
• 58 Tzatha E, DeAngelis LM. Chemotherapy-induced peripheral neuropathy. Oncology (Williston Park) 2016; 30 (03) 240-244
• 59 Bennett CL, Lawson VH, Brickell KL. et al. Late-onset hereditary axonal neuropathies. Neurology 2008; 71 (01) 14-20
• 60 Faber CG, Lauria G, Merkies IS. et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A 2012; 109 (47) 19444-19449
• 61 Hillis JM, Milligan TA. Teaching the neurological examination in a rapidly evolving clinical climate. Semin Neurol 2018; 38 (04) 428-440
• 62 Störmer S, Gerner HJ, Grüninger W. et al. Chronic pain/dysaesthesiae in spinal cord injury patients: results of a multicentre study. Spinal Cord 1997; 35 (07) 446-455
• 63 Truini A, Barbanti P, Pozzilli C, Cruccu G. A mechanism-based classification of pain in multiple sclerosis. J Neurol 2013; 260 (02) 351-367
• 64 Burke D, Wissel J, Donnan GA. Pathophysiology of spasticity in stroke. Neurology 2013; 80 (03, Suppl 2): S20-S26
• 65 Klingner CM, Witte OW. Somatosensory deficits. Handb Clin Neurol 2018; 151: 185-206
• 66 Bromberg MB. An approach to the evaluation of peripheral neuropathies. Semin Neurol 2010; 30 (04) 350-355
• 67 Dineen J, Freeman R. Autonomic neuropathy. Semin Neurol 2015; 35 (04) 458-468
• 68 Rolke R, Baron R, Maier C. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006; 123 (03) 231-243
• 69 Centers for Disease Control and Prevention (CDC). Prevalence and most common causes of disability among adults--United States, 2005. MMWR Morb Mortal Wkly Rep 2009; 58 (16) 421-426
• 70 Mozaffarian D, Benjamin EJ, Go AS. et al; Writing Group Members, American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: a report from the American Heart Association. Circulation 2016; 133 (04) e38-e360
• 71 Klit H, Finnerup NB, Andersen G, Jensen TS. Central poststroke pain: a population-based study. Pain 2011; 152 (04) 818-824
• 72 Bowsher D, Leijon G, Thuomas KA. Central poststroke pain: correlation of MRI with clinical pain characteristics and sensory abnormalities. Neurology 1998; 51 (05) 1352-1358
• 73 Garcia-Larrea L, Mauguière F. Pain syndromes and the parietal lobe. Handb Clin Neurol 2018; 151: 207-223
• 74 Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology 1995; 45 (07) 1294-1296
• 75 Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology 1988; 38 (12) 1830-1834
• 76 Truini A, Galeotti F, La Cesa S. et al. Mechanisms of pain in multiple sclerosis: a combined clinical and neurophysiological study. Pain 2012; 153 (10) 2048-2054
• 77 Levi R, Hultling C, Nash MS, Seiger A. The Stockholm spinal cord injury study: 1. Medical problems in a regional SCI population. Paraplegia 1995; 33 (06) 308-315
• 78 Ravenscroft A, Ahmed YS, Burnside IG. Chronic pain after SCI. A patient survey. Spinal Cord 2000; 38 (10) 611-614
• 79 Rintala DH, Loubser PG, Castro J, Hart KA, Fuhrer MJ. Chronic pain in a community-based sample of men with spinal cord injury: prevalence, severity, and relationship with impairment, disability, handicap, and subjective well-being. Arch Phys Med Rehabil 1998; 79 (06) 604-614
• 80 Titulaer MJ, Soffietti R, Dalmau J. et al; European Federation of Neurological Societies. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 2011; 18 (01) 19-e3
• 81 Gorson KC, Ropper AH, Muriello MA, Blair R. Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barré syndrome. Neurology 1996; 47 (03) 813-817
• 82 Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the spinal cord, nerve, and muscle. Muscle Nerve 2000; 23 (12) 1800-1818
• 83 Donofrio PD, Albers JW. AAEM minimonograph #34: polyneuropathy: classification by nerve conduction studies and electromyography. Muscle Nerve 1990; 13 (10) 889-903
• 84 Kincaid JC. Neurophysiologic studies in the evaluation of polyneuropathy. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1263-1275
• 85 Dimachkie MM, Saperstein DS. Acquired immune demyelinating neuropathies. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1241-1260
• 86 Li Y. Axonal sensorimotor polyneuropathies. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1378-1393
• 87 Allen JA. Chronic demyelinating polyneuropathies. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1310-1331
• 88 Rosow LK, Amato AA. The role of electrodiagnostic testing, imaging, and muscle biopsy in the investigation of muscle disease. Continuum (Minneap Minn) 2016; 22 (6, Muscle and Neuromuscular Junction Disorders): 1787-1802
• 89 Siao P, Kaku M. A clinician's approach to peripheral neuropathy. Semin Neurol 2019; 39 (05) 519-530
• 90 Khoshnoodi MA, Truelove S, Burakgazi A, Hoke A, Mammen AL, Polydefkis M. Longitudinal assessment of small fiber neuropathy: evidence of a non–length-dependent distal axonopathy. JAMA Neurol 2016; 73 (06) 684-690
• 91 Waheed W, Boyd J, Khan F, Mount SL, Borden NM, Tandan R. Double trouble: para-neoplastic anti-PCA-2 and CRMP-5-mediated small fibre neuropathy followed by chorea associated with small cell lung cancer and evolving radiological features. BMJ Case Rep 2016; 2016: bcr2016215158
• 92 Boruchow SA, Gibbons CH. Utility of skin biopsy in management of small fiber neuropathy. Muscle Nerve 2013; 48 (06) 877-882
• 93 Üçeyler N, Zeller D, Kahn AK. et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain 2013; 136 (Pt 6): 1857-1867
• 94 Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H. et al. Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study. J Neurol Sci 2014; 347 (1-2): 143-147
• 95 Doppler K, Rittner HL, Deckart M, Sommer C. Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain 2015; 156 (11) 2319-2325
• 96 Oaklander AL, Herzog ZD, Downs HM, Klein MM. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 2013; 154 (11) 2310-2316
• 97 Caro XJ, Winter EF. Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 2014; 66 (07) 1945-1954
• 98 Faber CG, Hoeijmakers JG, Ahn HS. et al. Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012; 71 (01) 26-39
• 99 Farhad K, Traub R, Ruzhansky KM, Brannagan III TH. Causes of neuropathy in patients referred as “idiopathic neuropathy”. Muscle Nerve 2016; 53 (06) 856-861
• 100 Terkelsen AJ, Karlsson P, Lauria G, Freeman R, Finnerup NB, Jensen TS. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol 2017; 16 (11) 934-944
• 101 Tavee JO. Immune axonal polyneuropathy. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1394-1410
• 102 Ando Y, Coelho T, Berk JL. et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis 2013; 8 (01) 31
• 103 Iodice V, Sandroni P. Autonomic neuropathies. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1373-1397
• 104 Barohn RJ, Amato AA. Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin 2013; 31 (02) 343-361
• 105 Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981; 10 (03) 222-226
• 106 Jann S, Beretta S, Bramerio M, Defanti CA. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve 2001; 24 (09) 1197-1201
• 107 Johannsen L, Smith T, Havsager AM. et al. Evaluation of patients with symptoms suggestive of chronic polyneuropathy. J Clin Neuromuscul Dis 2001; 3 (02) 47-52
• 108 Lubec D, Müllbacher W, Finsterer J, Mamoli B. Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases. Postgrad Med J 1999; 75 (890) 723-727
• 109 McLeod JG, Tuck RR, Pollard JD, Cameron J, Walsh JC. Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 1984; 47 (05) 530-535
• 110 Notermans NC, Wokke JH, Franssen H. et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993; 56 (10) 1066-1071
• 111 Wolfe GI, Baker NS, Amato AA. et al. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 1999; 56 (05) 540-547
• 112 Russell JA. General approach to peripheral nerve disorders. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1241-1262
• 113 Bowley MP, Ropper AH. Neuropathies in systemic disease. Semin Neurol 2015; 35 (04) 431-447
• 114 Gwathmey KG. Sensory neuronopathies. Muscle Nerve 2016; 53 (01) 8-19
• 115 Krishnan AV, Kiernan MC. Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve 2007; 35 (03) 273-290
• 116 England JD, Gronseth GS, Franklin G. et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (02) 177-184
• 117 Raheja D, Specht C, Simmons Z. Paraproteinemic neuropathies. Muscle Nerve 2015; 51 (01) 1-13
• 118 Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 1991; 30 (01) 54-61
• 119 Kelly Jr JJ, Kyle RA, O'Brien PC, Dyck PJ. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 1981; 31 (11) 1480-1483
• 120 Kissel JT, Mendell JR. Neuropathies associated with monoclonal gammopathies. Neuromuscul Disord 1996; 6 (01) 3-18
• 121 Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med 1998; 338 (22) 1601-1607
• 122 Huan MC. Laboratory evaluation of peripheral neuropathy. Semin Neurol 2010; 30 (04) 337-349
• 123 Dispenzieri A, Kyle R, Merlini G. et al; International Myeloma Working Group. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009; 23 (02) 215-224
• 124 Nobile-Orazio E. Paraproteinemic related neuropathies. Presented at the International Myeloma Workshop—International Workshop on Waldenstrom's macroglobulinemia. Fondazione Ferrata Storti, Italy; 2007
• 125 International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121 (05) 749-757
• 126 Nobile-Orazio E, Barbieri S, Baldini L. et al. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies. Acta Neurol Scand 1992; 85 (06) 383-390
• 127 Lopate G, Pestronk A, Kornberg AJ, Yue J, Choksi R. IgM anti-sulfatide autoantibodies: patterns of binding to cerebellum, dorsal root ganglion and peripheral nerve. J Neurol Sci 1997; 151 (02) 189-193
• 128 Petratos S, Turnbull VJ, Papadopoulos R, Ayers M, Gonzales MF. High-titre IgM anti-sulfatide antibodies in individuals with IgM paraproteinaemia and associated peripheral neuropathy. Immunol Cell Biol 2000; 78 (02) 124-132
• 129 Kelly Jr JJ, Kyle RA, O'Brien PC, Dyck PJ. The natural history of peripheral neuropathy in primary systemic amyloidosis. Ann Neurol 1979; 6 (01) 1-7
• 130 Ramchandren S, Lewis RA. Monoclonal gammopathy and neuropathy. Curr Opin Neurol 2009; 22 (05) 480-485
• 131 Silberman J, Lonial S. Review of peripheral neuropathy in plasma cell disorders. Hematol Oncol 2008; 26 (02) 55-65
• 132 Sommer C. Nerve and skin biopsy in neuropathies. Curr Opin Neurol 2018; 31 (05) 534-540
• 133 Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst 2008; 13 (01) 27-46
• 134 Tavee JO. Immune axonal polyneuropathy. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1394-1410
• 135 Boerkoel CF, Takashima H, Lupski JR. The genetic convergence of Charcot-Marie-Tooth disease types 1 and 2 and the role of genetics in sporadic neuropathy. Curr Neurol Neurosci Rep 2002; 2 (01) 70-77
• 136 Boerkoel CF, Takashima H, Garcia CA. et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002; 51 (02) 190-201
• 137 Hoogendijk JE, Hensels GW, Gabreëls-Festen AA. et al. De-novo mutation in hereditary motor and sensory neuropathy type I. Lancet 1992; 339 (8801): 1081-1082
• 138 Ramchandren S. Charcot-Marie-Tooth disease and other genetic polyneuropathies. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1360-1377
• 139 Fridman V, Reilly M. Inherited neuropathies. Semin Neurol 2015; 35 (04) 407-423
• 140 Hobson-Webb LD, Juel VC. Common entrapment neuropathies. Continuum (Minneap Minn) 2017; 23 (2, Selected Topics in Outpatient Neurology): 487-511
• 141 Moghekar AR, Moghekar AR, Karli N, Chaudhry V. Brachial plexopathies: etiology, frequency, and electrodiagnostic localization. J Clin Neuromuscul Dis 2007; 9 (01) 243-247
• 142 Harper Jr CM, Thomas JE, Cascino TL, Litchy WJ. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG. Neurology 1989; 39 (04) 502-506
• 143 Karli N. et al. Lumbosacral plexopathies: etiology, frequency, and electrodiagnostic localization. J Clin Neuromuscul Dis 2007; 8 (04) 195-201
• 144 Jaeckle KA. Neurologic manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol 2010; 30 (03) 254-262
• 145 Gilden D. Varicella-zoster virus infections. Continuum (Minneap Minn) 2015; 21 (6 Neuroinfectious Disease): 1692-1703
• 146 Malek E, Salameh JS. Common entrapment neuropathies. Semin Neurol 2019; 39 (05) 549-559
• 147 Arnold WD, Elsheikh BH. Entrapment neuropathies. Neurol Clin 2013; 31 (02) 405-424
• 148 Sène D. Small fiber neuropathy: diagnosis, causes, and treatment. Joint Bone Spine 2018; 85 (05) 553-559
• 149 Oaklander AL, Nolano M. Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol 2019; 76 (10) 1240-1251
• 150 Üçeyler N, Sommer C. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 2013; 154 (11) 2569
• 151 Jay GW. Practical Guide to Chronic Pain Syndromes. CRC Press; 2016
• 152 Clauw DJ. Fibromyalgia: a clinical review. JAMA 2014; 311 (15) 1547-1555
• 153 Boehnke KF. Pain management: assembling a tool kit, building a life. JAMA 2018; 320 (21) 2201-2202
• 154 Collins KL, Russell HG, Schumacher PJ. et al. A review of current theories and treatments for phantom limb pain. J Clin Invest 2018; 128 (06) 2168-2176
• 155 Bereznyakova O, Dupré N. Spastic ataxias. Handb Clin Neurol 2018; 155: 191-203
• 156 Coyle L, Entezaralmahdi M, Adeola M, De Hoyos P, Mehed A, Varon J. The perfect storm: copper deficiency presenting as progressive peripheral neuropathy. Am J Emerg Med 2016; 34 (02) 340.e5-340.e6
• 157 Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol 2014; 120: 915-926
• 158 Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1293-1306
• 159 McCarberg B, D'Arcy Y, Parsons B, Sadosky A, Thorpe A, Behar R. Neuropathic pain: a narrative review of etiology, assessment, diagnosis, and treatment for primary care providers. Curr Med Res Opin 2017; 33 (08) 1361-1369
• 160 Szok D, Tajti J, Nyári A, Vécsei L. Therapeutic approaches for peripheral and central neuropathic pain. Behav Neurol 2019; 2019: 8685954
• 161 Bates D, Schultheis BC, Hanes MC. et al. A comprehensive algorithm for management of neuropathic pain. Pain Med 2019; 20 (Suppl. 01) S2-S12